These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25231593)

  • 21. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.
    Alexandrou ME; Balafa O; Sarafidis P
    Am J Nephrol; 2020; 51(8):589-612. PubMed ID: 32721969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides.
    Gargani L; Frassi F; Soldati G; Tesorio P; Gheorghiade M; Picano E
    Eur J Heart Fail; 2008 Jan; 10(1):70-7. PubMed ID: 18077210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volume status and arterial stiffness evaluation in peritoneal dialysis patients.
    Fornazarič D; Antonič M; Knap B
    Clin Nephrol; 2021 Suppl; 96(1):74-79. PubMed ID: 34643495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.
    Iwasaki M; Joki N; Tanaka Y; Ikeda N; Hayashi T; Kubo S; Asakawa T; Takahashi Y; Hirahata K; Imamura Y; Hase H
    Nephrology (Carlton); 2013 Jul; 18(7):497-504. PubMed ID: 23574011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome.
    Nalcacioglu H; Ozkaya O; Baysal K; Kafali HC; Avci B; Tekcan D; Genc G
    Nefrologia (Engl Ed); 2018; 38(1):48-56. PubMed ID: 28751054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry weight assessment by combined ultrasound and bioimpedance monitoring in low cardiovascular risk hemodialysis patients: a randomized controlled trial.
    Siriopol D; Onofriescu M; Voroneanu L; Apetrii M; Nistor I; Hogas S; Kanbay M; Sascau R; Scripcariu D; Covic A
    Int Urol Nephrol; 2017 Jan; 49(1):143-153. PubMed ID: 27928711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H; Dohi Y
    Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients.
    Pietrzak A; Bartosinska J; Blaszczyk R; Chodorowska G; Brzozowski W; Hercogova J; Donica H; Lotti T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):1010-4. PubMed ID: 24735175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.